Antifungal and Antibiofilm Activities of Ozonated Sunflower Oil against Candida albicans Strains: A Pilot Study and Clinical Perspectives
Matéus Simplício Araújo, Júlio César Sousa Prado, Francisca Lidiane Linhares de Aguiar, Flávia de Araújo Silva, Yann Nobre Viana, Joelson Pessoa Dantas, Ana Paula Anzolin, Poliana Lima Bastos, Raquel Oliveira dos Santos Fontenelle, Francisco Cesar Barroso Barbosa
Archives of Current Research International · pp. 494–502 · Published 7 Jun 2024
10.9734/acri/2024/v24i5726Abstract
Aims: This study aimed to assess the antifungal and antibiofilm activities of ozonized (OGOZ) and non-ozonized (OG) Helianthus annuus (sunflower) oil against Candida albicans strains. Study Design: Laboratory-based study. Place and Duration of Study: Microbiology Laboratory of the Federal University of Ceará and State University of Vale do Acaraú, from August 2023 to Decembrer of the same year. Methodology: Seven clinical strains and one reference strain (ATCC 90028) were examined. Initially, antimicrobial susceptibility testing (AST) was performed using a modified disk diffusion method with both OGOZ and OG. Strains that displayed sensitivity were then subjected to a broth microdilution assay to determine the Minimum Inhibitory Concentration (MIC) and Minimum Fungicidal Concentration (MFC). The biofilm assay was conducted specifically with the C. albicans reference strain. Results: AST results showed that all strains exhibited inhibition zones with OGOZ, while non-ozonized oil did not produce inhibition zones. MIC values ranged from 0.15 to 2.50 mg/mL, with one clinical strain (LABMIC H10) demonstrating an MIC value 16 times lower than other strains. None of the strains reached MFC at the tested concentrations. In terms of biofilm formation, application of MIC and twice the MIC resulted in a 48,6% and 85% reduction in mature biofilms, respectively. Conclusion: The findings indicate that OGOZ has fungistatic and antibiofilm effects, highlighting its potential as a promising agent for bioprospecting. Further clinical trials are essential to evaluate its therapeutic potential for managing infectious diseases such as oral candidiasis.
Cited by 0
No indexed citations yet.
Related research
- Knowledge, Attitude and Predisposing Risk Factors of Non-Albican Vulvovaginal Candidiasis among Symptomatic Women in Port Harcourt — shares topic coverage
- Aetiologic Agents of Vaginitis in Sexually Active Women in a Traditional Sprawling Town in the Niger Delta, South – South Nigeria — shares topic coverage
- The Prevalence of Candida albicans and Trichomonas vaginalis among First Year Female Students of a Tertiary Institution in Southeastern Nigeria — shares topic coverage
- Biodegradation of Palm Oil Mill Effluent (POME) and Lipase Activity by Pseudomonas aeruginosa, Bacillus subtilis and Candida albicans — shares topic coverage
- Characterization of Vaginal Lactobacillus Strains and Their Potential Antagonistic Effects on Candida albicans — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.